Global Homocysteine Testing Market Size study & Forecast, by Type (Folic Acid, Pyridoxine, Cobalamin), Form (Tablet, Syrup, Others), Distribution Channel (Hospital Pharmacies, Drug Stores and Others) and Regional Analysis, 2022-2029

Global Homocysteine Testing Market Size study & Forecast, by Type (Folic Acid, Pyridoxine, Cobalamin), Form (Tablet, Syrup, Others), Distribution Channel (Hospital Pharmacies, Drug Stores and Others) and Regional Analysis, 2022-2029

Global Homocysteine Testing Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8% over the forecast period 2022-2029. Homocysteine and its metabolites abnormally accumulate in the blood and urine as a result of the condition known as homocystinuria. The amount of homocysteine in human serum or plasma is measured using homocysteine reagents. The biosynthesis of the amino acid homocysteine occurs as a byproduct of the metabolism of methionine. The market growth is expected to be driven by key factors such as increasing cardiovascular disease and neurological disorders and increasing per capita healthcare expenditure.

The World Health Organization states that the leading cause of mortality worldwide is cardiovascular disease (CVD). According to estimates, 17.9 million deaths worldwide in 2019 were attributable to CVDs, or 32% of all fatalities. Heart attack and stroke deaths accounted for 85% of these fatalities. Additionally, the article ""U.S Alcohol consumption on the low end of recent measurements"" from August 2021 indicated that 60% of American people now consume alcoholic drinks, down from 65%. According to the survey, Americans now consume 3.6 drinks on average per week as opposed to 4.0. However, the Lack of awareness regarding the deficiency of vitamins in blood stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Homocysteine Testing Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the Global market revenue share owing to high homocysteine testing and increasing junk food consumption in the region. The Asia Pacific is expected to be the fastest growing region owing to the large patient pool in the forecast years.

Major market players included in this report are:
F. Hoffmann La Roche
Sekisui Diagnostics
Jamp Pharma Corporation
Machaon Diagnostics Inc.
Kripps Pharmacy Ltd
ARUP laboratories
Cardinal Health, Inc
Pfizer Inc
Mckesson Corporation
Teligent, Inc

Recent Developments in the Market:
 Cardinal Health received a USD 57.8 million contract in April 2021. The contract included options that the US Department of Health and Human Services might exercise to raise the total to USD 91.6 million.
 A four-story, 220,000-square-foot laboratory owned by ARUP Laboratories will formally open in Salt Lake City in June 2021. It has entire lab automation to further expand testing capacity and support ARUP's expansion, and it is built to optimize the quality of laboratory testing.

Global Homocysteine Testing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Form, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Type:
Folic Acid
Pyridoxine
Cobalamin
By Form:
Tablet
Syrup
Others
By Distribution Channel:
Hospital Pharmacies
Drug Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

F. Hoffmann La Roche
Sekisui Diagnostics
Jamp Pharma Corporation
Machaon Diagnostics Inc.
Kripps Pharmacy Ltd
ARUP laboratories
Cardinal Health, Inc
Pfizer Inc
Mckesson Corporation
Teligent, Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.